Germany

Because of cost pressures from Asian generic active pharmaceutical ingredient (API) manufacturers and new pseudoephedrine legislation in the US, the world's largest chemical company... 2006-09-05

Confirming its commitment to the growing biotechnology sector, German firm Merck KGaA has decided to construct a biopharmaceutical production plant at its headquarters in Darmstadt,... 2006-08-30

German pharmaceutical companies have strongly criticised a Health Ministry working paper on the healthcare reform draft legislation which could lead to price caps for newly launched... 2006-08-29

Japan's Daiichi-Sankyo is to redouble efforts to expand in Europe. Sankyo alone had sales of EUR322mn (US$406mn) in the region last year. With over 1,000 sales representatives already... 2006-07-24

German generic firm Stada - which is currently in the process of buying Serbia's Hemofarm - has stated that it is interested in further acquisitions in the region, ideally in the... 2006-07-21

Affirming its commitment to Poland, German firm Boehringer Ingelheim has renewed its lease covering its premises at the Mokotów Business Park, Warsaw. The company's operations in... 2006-07-21

German firm Stada is poised to acquire Serbia's largest drug manufacturer - Hemofarm - for US$608mn to exploit the country's low cost base and Eastern Europe's booming generics market.... 2006-07-17

German generic company Stada Arzneimittel is to sell its unprofitable US unit to local firm DAVA Pharmaceuticals for US$40mn, signalling a disappointing exit from the world's largest... 2006-07-14

Outstripping the pharmaceutical sector considerably, the German biotechnology industry is expected grow by 10% annually until 2010, signalling the end of recovery from the negative... 2006-07-05

German drug retailer Andreae-Noris AG (ANZAG) has purchased a 60% interest in Romanian pharmaceutical wholesaler Farmexpert to extend its distribution network in Eastern Europe. The... 2006-06-13